Representatives of BRICs countries and international organizations visit member enterprises of China Council for the promotion of drugs

Source: China Council for the promotion of drugs 2014-10-28 in the morning of October 27, 2014, some participants in the 2014 international pharmaceutical innovation cooperation forum hosted by the national health and Family Planning Commission and hosted by China Council for the promotion of drugs visited Yabao pharmaceutical Beijing Pharmaceutical Research Institute, a member enterprise of China Council for the promotion of drugs Foreign guests attending the visit mainly included Jorge Bermudez, vice president of fiocruz foundation, Ministry of health of Brazil, thamizhanban Pillay, deputy director of the Department of regulatory compliance, Ministry of health of South Africa, mariangela Simao, director of human rights, gender, prevention and mobilization, UNAIDS, and Klara, head of essential drugs and health technology, Western Pacific region, who Tisocki et al Ge Jisheng, vice president of Yabao pharmaceutical Beijing Pharmaceutical Research Institute, received the guests He extended a warm welcome to the visit of representatives of BRICs countries and international organizations President Ge first introduced the overall situation and R & D strategy of Yabao pharmaceutical Yabao pharmaceutical is committed to the research of innovative medicine In recent years, the group is building production lines in accordance with European and American standards At present, the production line of Yabao pharmaceutical Beijing Biomedical Company has passed the FDA certification, and its solid preparation production line fully conforms to the cGMP standard of the US FDA, which indicates that Yabao pharmaceutical industry has entered the international fast lane Subsequently, accompanied by the staff of Yabao pharmaceutical Beijing Pharmaceutical Research Institute, the foreign guests visited the cGMP production line and R & D Laboratory of Yabao pharmaceutical The two sides conducted in-depth exchanges and discussions on new drug R & D and technology introduction As an important part of the "2014 International Pharmaceutical Innovation Cooperation Forum", the visit deepened BRICs countries' and relevant international organizations' understanding of the development level of innovative pharmaceutical enterprises in China, which is of great significance to promote the participation of Chinese pharmaceutical industry in international cooperation in pharmaceutical innovation and R & D President Ge introduces the general situation of Yabao pharmaceutical industry Foreign guests visit the production line of Yabao pharmaceutical industry Group photo of the visit